1.
Scortichini M, Ruggieri A, Cattaneo A, Mascagni P, Sciattella P. Cost-analysis from real-world REDS study on dalbavancin in inpatient treatment of acute bacterial skin and skin structure infections. Grhta [Internet]. 2025 Jun. 9 [cited 2025 Jun. 15];12(1):151-7. Available from: https://journals.aboutscience.eu/index.php/grhta/article/view/3363